|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Aronora, Inc.
| Aronora, Inc. 455 Mission Bay Blvd South, Suite 145 San Francisco, CA 94158 | |
| | Phone: | (503) 530-6842 | Year Established: | 2007 | Main Contact: | András Gruber, MD, Ph.D., Co-Founder, President & CEO | | Other Contacts: | Erik I. Tucker, Ph.D., Co-Founder & COO
| |
| Company Description | Aronora is a start-up biotech company established for the commercialization of proprietary anticoagulant (blood thinning) products that do not cause bleeding, thus they can be safely used in hard-to-treat blood clot diseases, such as ischemic stroke, heart attack, or those associated with severe infections.
The company has received a Fast-Track (Phase I/II) SBIR from the National Heart, Lung & Blood Institute for the development of WE-thrombin. The company has also received an Advanced Technology Phase I SBIR from the National Institute of Allergy & Infectious Diseases to support development of our factor XI inhibitor for sepsis. Aronora is also seeking private investment to support product development. The NIH and AHA have invested $5M in related basic innovative research to date. | |
|
|
|
|
|